Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04664881 · ClinicalTrials.gov registry record · NA
Home Telemonitoring In Patients After Myocardial Infarction
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT04664881: Completed NA study, sponsored by Mayo Clinic.
NCT04664881 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 195 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04664881, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
This study is being done to determine if taking an electrocardiogram (ECG) by a portable device (SmartHeart) followed by a phone call will improve patient outcomes by early recognition of abnormalities and decrease emergency room visits and hospital readmissions compared to standard therapy alone.
Interventions
- DEVICE SmartHeart Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2020-10-14 |
| Est. Completion | 2024-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04664881
The ClinicalTrials.gov registry entry for NCT04664881 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SmartHeart Device is the first listed.
NCT04664881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04664881 about?
NCT04664881 is a clinical study titled "Home Telemonitoring In Patients After Myocardial Infarction". This study is being done to determine if taking an electrocardiogram (ECG) by a portable device (SmartHeart) followed by a phone call will improve patient outcomes by early recognition of abnormalities and decrease emergency room visits and hospital readmissions compared to standard therapy alone.
What is the current status of trial NCT04664881?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2020-10-14. Estimated completion is 2024-05-02.
What interventions are being tested in trial NCT04664881?
The interventions under investigation include: SmartHeart Device (DEVICE).
Who is sponsoring clinical trial NCT04664881?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.